Singapore markets open in 1 hour 38 minutes

Iterum Therapeutics plc (ITRM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.5900+0.0500 (+3.25%)
At close: 04:00PM EDT
1.6000 +0.01 (+0.63%)
After hours: 05:24PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.5400
Open1.5100
Bid1.5600 x 100
Ask1.6300 x 100
Day's range1.4500 - 1.6200
52-week range0.6220 - 2.5000
Volume237,717
Avg. volume205,204
Market cap26.119M
Beta (5Y monthly)2.36
PE ratio (TTM)N/A
EPS (TTM)-2.9600
Earnings date10 May 2024 - 14 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est6.50
  • GlobeNewswire

    Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem

    --First Oral Penem in the U.S. and Second New Oral Treatment for uUTIs in Over 25 Years, if approved-- --Potential Approval Early Q4 2024-- DUBLIN, Ireland and CHICAGO, April 29, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that it has resubmitte

  • Insider Monkey

    Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript

    Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript March 28, 2024 Iterum Therapeutics plc beats earnings expectations. Reported EPS is $-0.94, expectations were $-1.02. ITRM isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, everyone, and welcome to the […]

  • Thomson Reuters StreetEvents

    Q4 2023 Iterum Therapeutics PLC Earnings Call

    Q4 2023 Iterum Therapeutics PLC Earnings Call